Key Takeaways
- Volume surged but mix diluted revenue: Volume grew 43% YoY, yet revenue rose only ~12% because the faster-growing FMCG/hygiene segment carries lower realizations than textiles.
- Margins hit a new plateau: EBITDA margin reached a level management calls sustainable, driven by specialty solutions and direct-to-customer branding, not temporary destocking.
- Textile demand snapped back: A sharp recovery in textile volumes, especially in finishing, is restoring the highest-stickiness, highest-realization part of the portfolio.
- The FMCG bet is scaling, slowly: Over 100 detergent customers are now active, and a large Patanjali-sized win is in trial orders, but global MNC onboarding remains a multi-year effort with no timeline.
- What to watch next quarter: Whether the textile recovery sustains and lifts the revenue mix back toward higher realizations, and any progress converting FMCG trial orders into recurring volumes.
Volume-Mix Disconnect
- Volume exploded, revenue lagged: Volume grew 43% YoY while revenue grew ~12%, because the incremental volume came disproportionately from cleaning/hygiene FMCG where average realization prices are lower than textiles.
- Textile realizations held firm: Realization in textiles remained consistent; the dilution is purely a mix shift, not price erosion in the core business.
- Finishing is the anchor: Finishing chemicals make up 60% of textile volumes and are the most sustainable business because changing a finish supplier risks ruining an entire fabric batch, making customers deeply reluctant to switch.
Tibrewala: "finishing is today also, let's say, 60% of our textile volumes. And that is something which is the most sustainable business because no textile company will be able, generally, it's not possible to change the finish easily. And we are the masters in the finishing of textiles."
Margin Structure & Sustainability
- EBITDA margin is structurally higher: The improvement reflects a shift toward specialty chemicals and solutions, plus direct-to-customer branding that captures margin previously retained by European MNC intermediaries, not a one-off destocking benefit.
- The European competitor unwind: European giants like Archroma, Huntsman and BASF operated with ~400% gross margins but could not convert them to bottom lines due to high overheads; their consolidation has made Fineotex more strategic, and the company now sells directly to end-customers under its own brands.
- Management's confidence: Over the last 8-10 quarters, EBITDA margin has expanded roughly 200 bps per quarter on average, and management expects to at least sustain current levels given the product mix and demand environment.
- Raw material tailwind: Commodity chemical prices have bottomed out; if they stay low, that benefits Fineotex as a raw material buyer, and if they recover, management argues margins may not necessarily compress because inventory levels and industry mood play a role.
Textile: The Core Engine Returns
- Demand recovered sharply in Q2: Textile customers, especially in bedsheets, rebounded; names like IndoCounts, Himatsinka and Mohan Spentex are performing well.
- Stickiness is structural, not price-led: The cost of textile chemicals is negligible relative to the value of fabric, but the risk of a batch failure is catastrophic, so customers do not switch on price. Dependability and reliability govern retention.
- Specialty positioning: Management describes Fineotex as the "cardiologists of the textile industry," focused on high-end specialty chemicals rather than commodity volumes.
- Wallet-share strategy: The company grows by offering complete solution packages where customers take the entire basket of products, deepening share of wallet with existing accounts rather than chasing new logos.
Tibrewala: "Nobody will change the salt of the food. Similarly, the textile customers do not change those chemicals, which they are using over the period of years, because the cost for them is negligible. At the same time, the risk is very high. If something goes wrong, the entire fabric is wasted. So, it's not a price game."
FMCG & Hygiene: The Long Build
- Customer base is broadening: The company has touched more than 100 customers in the detergent business, and a recent technical seminar in Northeast India drew 60-70 mid-level corporate companies from the cleaning hygiene detergent field.
- The Patanjali proof point: Patanjali, a ~₹50,000 crore brand, took 2.5-3 years to start using Fineotex products and now uses them in its detergents, replacing multinational incumbents like BASF and Dow. This win serves as a testimonial for other large domestic players.
- Global MNCs are in evaluation: Certain big global MNCs are at the evaluation stage, but management cautions that these engagements take years of effort and offers no timeline for conversion.
- New product trials underway: Another product has started with the large detergent/cleaning customer and has just gone for trial orders; multiple categories beyond the two initially mentioned have already launched and started selling.
Tibrewala: "their trust on us is a testimonial that, this kind of like Rs. 50,000 crore brand is looking at us and accepting our products over to all the multinational chemical companies like BASF and Dow and things like that"
Capacity, Capex & Balance Sheet
- Capacity utilization rising: Utilization reached almost 68%, up from 62% last quarter, and management expects further improvement as demand returns in both textiles and FMCG.
- Capex plan: Around ₹50-60 crore planned for FY25, fully funded by internal accruals; the company intends to remain debt-free.
- Capacity expansion timeline: Any organic expansion, whether in an existing plant or a new one, needs roughly one to two years, so management is already looking at 2026 and preparing for the next growth phase.
- Inorganic discipline: The company is open to M&A discussions and keeps looking, but is very cash-disciplined; any acquisition must have proper synergy and a clear plan, and there is no hurry. A board meeting is scheduled to consider fundraising and debt for potential deals.
- ICRA upgrade: Long-term rating upgraded to ICRA A+ and short-term to ICRA A1+ during the quarter.
Competitive Moat & Business Model
- Former customers are now competitors: Fineotex previously supplied European MNC chemical companies who sold under their own brands at very high margins. Now the company goes direct to customers, branding its own products with documentation, factory audits, product audits and research.
- European inefficiency is Fineotex's opportunity: European competitors had 400% gross margins but could not generate adequate bottom lines due to high overheads and inefficient operations; their consolidation has opened space for Fineotex to become more strategic.
- Not a turnover play: Management explicitly positions the company as specialty-focused, not chasing volumes for their own sake, and sees the ability to double business just by increasing wallet share with existing customers.
Tibrewala: "If we are the cardiologists of the textile industry, we do not want to be the general physicians, let's put it like that."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA margin | Maintain at least current levels (24-26% range) | Ongoing, based on product mix and demand |
| Capacity utilization | Further increase from 68% as demand returns | As textile and FMCG demand recover |
| Capex | ₹50-60 crore, funded by internal accruals, remain debt-free | FY25 |
| Capacity expansion | New or expanded plant to support next growth phase | ~1-2 years from decision; targeting 2026 readiness |
| Exports | Revive through increased exposure and 4-5 international exhibitions yearly | Ongoing |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Operational revenue | ₹145.3 cr |
| EBITDA | ₹38.2 cr, up 52.3% YoY, margin at 26.3% |
| PAT | ₹31.5 cr, up 51.6% YoY, margin at 21.7% |
| H1 FY24 operational revenue | ₹277.5 cr |
| H1 FY24 EBITDA | ₹69.7 cr, up 36.0% YoY, margin at 25.1% |
| H1 FY24 PAT | ₹57.6 cr, up 40.3% YoY, margin at 20.8% |
| Annualized ROCE | 36.4% |
| Annualized ROE | 30.3% |
| Volume growth | 43% YoY |
| Capacity utilization | 68%, up from 62% in Q1 FY24 |
| Textile volume share | 44% of total volumes |
| Textile revenue share | 59% of total revenues |
| FMCG revenue contribution (H1 FY24) | 40% broadly |
| Capex plan for FY25 | ₹50-60 cr on the higher level |
| Cash on books | ~₹200 cr |